New multiple sclerosis research may help predict the progression of MS based on the increased presence of a substance in the stool of MS patients.
Doctors analyze stool to detect parasites and colorectal cancer. It is understood that the gut microbiome is abnormal in those with MS and other diseases and that this disruption can influence disease through many different pathways.
In the 2024 study entitled, Stool GFAP Is Elevated in Progressive MS, Is Associated with Disability, and Predicts Disease Worsening, a Harvard Medical School research group concluded that analyzing the stool of MS patients may help doctors predict which patients are likely to experience greater progression of this disease.
The stool from 26 healthy volunteers, 61 relapsing remitting multiple sclerosis patients and 28 progressive MS patients were analyzed for glial fibrillary acidic protein (GFAP). Two years later, the participants had their stool analyzed again and completed the Expanded Disability Status Scale (EDSS) and Symbol Digit Modality Testing (SDMT) surveys to assess cognitive function and quality of life.
GFAP in the blood of MS patients has been shown to predict disease worsening in MS. The researchers discovered that GFAP in the stool of progressive MS patients were 87% higher than in those with relapsing remitting MS and 103% higher than in the healthy volunteers. These differences were statistically significant.
Higher concentrations of GFAP in the stool correlated with an increase in EDSS score and a lower SDMT score which both indicated a worsening of MS over two years. Higher stool GFAP was also significantly correlated with worsening in seven NeuroQoL areas: upper and lower extremity function, ability to participate in and satisfaction with social roles, stigma, cognitive function and anxiety.[i]
The researchers concluded that GFAP may serve as new biomarker linked to disease stage and that this may be another reliable way to predict the course of MS in patients. This in turn would help doctors select MS disease modifying drugs and help patients budget for home modifications as they become more disabled.
These researchers would like to use their discovery to support the current standard of care of multiple sclerosis, which attempts to manage the progression of the disease. This is not helpful for MS patients. Why aren’t they searching for a cure?
The discovery of GFAP in the stool of MS patients actually provides more evidence that multiple sclerosis is an infectious disease caused by a parasitic infestation.
GFAP is a protein this is produced by one of our genes when nerves are injured.
Recent evidence shows that the GFAP protein may be an excellent biomarker for traumatic brain, spinal cord injuries, stroke, severe forms of inflammatory bowel disease, such as ulcerative and infectious colitis, and neurological disorders like Parkinson’s disease.
Increased GFAP is not only present in people with advanced multiple sclerosis but also in those with many other inflammatory conditions.
Why are these researchers not interested in investigating why there is an increase in GFAP in the stool of MS patients? What is causing inflammation in the gut of patients with MS and other diseases?
If MS is a disease of the central nervous system, why is there so much inflammation in the digestive tract of MS patients?
Why are most scientific studies not conducted with the intention of finding the cause of disease, but rather to support the status quo?
Is it not a conflict of interest that the very companies that sell MS disease modifying drugs financially support the experts that decide how MS is diagnosed and treated? Is this why they are not interested in the mountain of evidence confirming that MS is an infectious disease?
There are real solutions to recover from parasites today!
To restore health, we must focus on treating the cause of inflammation, which are parasites. First, identify the enemy (parasites), then support the body and treat the parasites while following a holistic approach. When parasitic infections are treated effectively, we can overcome inflammation or disease.
If you’re frustrated with the fact that our standard of care STILL doesn’t offer a real solution for treating MS and other diseases, then click on the link below to watch Pam Bartha’s free masterclass training and discover REAL solutions that have allowed Pam and many others to live free from MS and other diseases.
CLICK Here to watch Pam’s masterclass training
Or take the Health Blocker Quiz to see if you could have parasite infections
References:
[i] https://www.neurology.org/doi/10.1212/WNL.0000000000206234
https://www.frontiersin.org/journals/cellular-neuroscience/articles/10.3389/fncel.2022.895871/full
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559283/
Clinically diagnosed with multiple sclerosis at the age of 28, Pam chose an alternative approach to recovery. Now decades later and still symptom free, she coaches others on how to treat the root cause of chronic disease, using a holistic approach. She can teach you how, too.
Pam is the author of Become a Wellness Champion and founder of Live Disease Free. She is a wellness expert, coach and speaker.
The Live Disease Free Academy has helped hundreds of Wellness Champions in over 15 countries take charge of their health and experience profound improvements in their life.
